TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4759-4768

  Andrade, Elva B ^a,b   Alves, Joana ^a,b   Madureira, Pedro ^a,b   Oliveira, Liliana ^a,b   Ribeiro, Adília ^a,b   Cordeiro Da Silva, Anabela ^a,b   Correia Neves, Margarida ^c,d   Trieu Cuot, Patrick ^e   Ferreira, Paula ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; LEUKOTRIENE B4; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GRAM NEGATIVE SEPSIS; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; JUVENILE ANIMAL; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NEWBORN; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; WILD TYPE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; DEFICIENCY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; MICROBIOLOGY; MORTALITY; NEUTROPHIL; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANIMALS; CELL MOVEMENT; FEMALE; INTERLEUKIN-10; LEUKOTRIENE B4; LIPOPEPTIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TOLL-LIKE RECEPTOR 2;

EID: 84885983093     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301752     Document Type: Article

References (63)

1. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564.
2. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7: 379-390.
3. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
4. Alves-Filho, J. C., A. de Freitas, M. Russo, and F. Q. Cunha. 2006. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit. Care Med. 34: 461-470.
5. Alves-Filho, J. C., A. Freitas, F. O. Souto, F. Spiller, H. Paula-Neto, J. S. Silva, R. T. Gazzinelli, M. M. Teixeira, S. H. Ferreira, and F. Q. Cunha. 2009. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. USA 106: 4018-4023.
6. Daubeuf, B., J. Mathison, S. Spiller, S. Hugues, S. Herren, W. Ferlin, M. KoscoVilbois, H. Wagner, C. J. Kirschning, R. Ulevitch, and G. Elson. 2007. TLR4/ MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J. Immunol. 179: 6107-6114.
7. Plitas, G., B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo. 2008. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205: 1277-1283.
8. Roger, T., C. Froidevaux, D. Le Roy, M. K. Reymond, A. L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra. 2009. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 106: 2348-2352.
9. Bieback, K., E. Lien, I. M. Klagge, E. Avota, J. Schneider-Schaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. Ter Meulen, and S. SchneiderSchaulies. 2002. Hemagglutinin protein of wild-type measles virus activates tolllike receptor 2 signaling. J. Virol. 76: 8729-8736.
10. Campos, M. A., I. C. Almeida, O. Takeuchi, S. Akira, E. P. Valente, D. O. Procópio, L. R. Travassos, J. A. Smith, D. T. Golenbock, and R. T. Gazzinelli. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167: 416-423.
11. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163: 3920-3927.
12. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by tolllike receptor 2. J. Biol. Chem. 274: 17406-17409.
13. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
14. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1-5.
15. Edwards, M. S., and C. J. Baker. 2005. Group B streptococcal infections. In Infectious diseases of the fetus and newborn infant, 6th Ed. J. S. Remington, and J. O. Klein, eds. Saunders, Philadelphia, p. 1091-1156.
16. Asplin, I. R., D. J. Carl, S. S. Way, and A. L. Jones. 2008. Role of Toll-like receptor 2 in innate resistance to Group B Streptococcus. Microb. Pathog. 44: 43-51.
17. Henneke, P., S. Morath, S. Uematsu, S. Weichert, M. Pfitzenmaier, O. Takeuchi, A. Müller, C. Poyart, S. Akira, R. Berner, et al. 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174: 6449-6455.
18. Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172: 4733-4743.
19. Jang, S., S. Uematsu, S. Akira, and P. Salgame. 2004. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J. Immunol. 173: 3392-3397.
20. Sing, A., D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C. J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196: 1017-1024.
21. Madureira, P., E. B. Andrade, B. Gama, L. Oliveira, S. Moreira, A. Ribeiro, M. Correia-Neves, P. Trieu-Cuot, M. Vilanova, and P. Ferreira. 2011. Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog. 7: e1002363.
22. Madureira, P., M. Baptista, M. Vieira, V. Magalhães, A. Camelo, L. Oliveira, A. Ribeiro, D. Tavares, P. Trieu-Cuot, M. Vilanova, and P. Ferreira. 2007. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J. Immunol. 178: 1379-1387.
23. Mancuso, P., C. Lewis, C. H. Serezani, D. Goel, and M. Peters-Golden. 2010. Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Infect. Immun. 78: 2264-2271.
24. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
25. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
26. Watanabe, N., and Y. Kobayashi. 1994. Selective release of a processed form of interleukin 1 alpha. Cytokine 6: 597-601.
27. Werman, A., R. Werman-Venkert, R. White, J. K. Lee, B. Werman, Y. Krelin, E. Voronov, C. A. Dinarello, and R. N. Apte. 2004. The precursor form of IL1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 101: 2434-2439.
28. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171: 465-475.
29. Mancuso, G., A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, and G. Teti. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172: 6324-6329.
30. Cummings, C. J., T. R. Martin, C. W. Frevert, J. M. Quan, V. A. Wong, S. M. Mongovin, T. R. Hagen, K. P. Steinberg, and R. B. Goodman. 1999. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162: 2341-2346.
31. Adams, J. M., C. J. Hauser, D. H. Livingston, R. F. Lavery, Z. Fekete, and E. A. Deitch. 2001. Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure. J. Trauma 51: 452-456, discussion 456-457
32. Zhang, X., E. Deriaud, X. Jiao, D. Braun, C. Leclerc, and R. Lo-Man. 2007. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J. Exp. Med. 204: 1107-1118.
33. Kollmann, T. R., J. Crabtree, A. Rein-Weston, D. Blimkie, F. Thommai, X. Y. Wang, P. M. Lavoie, J. Furlong, E. S. Fortuno, III, A. M. Hajjar, et al. 2009. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183: 7150-7160.
34. Chelvarajan, R. L., S. M. Collins, I. E. Doubinskaia, S. Goes, J. Van Willigen, D. Flanagan, W. J. De Villiers, J. S. Bryson, and S. Bondada. 2004. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J. Leukoc. Biol. 75: 982-994.
35. Benjamim, C. F., S. H. Ferreira, and F. Q. Cunha. 2000. Role of nitric oxide in the failure of neutrophil migration in sepsis. J. Infect. Dis. 182: 214-223.
36. Crosara-Alberto, D. P., A. L. Darini, R. Y. Inoue, J. S. Silva, S. H. Ferreira, and F. Q. Cunha. 2002. Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br. J. Pharmacol. 136: 645-658.
37. Bernstein, H. M., D. A. Calhoun, and R. D. Christensen. 2002. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr. Opin. Pediatr. 14: 91-94.
38. Gessler, P., N. Kirchmann, R. Kientsch-Engel, N. Haas, P. Lasch, and W. Kachel. 1993. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood 82: 3177-3182.
39. Levy, O. 2005. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotoxin Res. 11: 113-116.
40. Angelone, D. F., M. R. Wessels, M. Coughlin, E. E. Suter, P. Valentini, L. A. Kalish, and O. Levy. 2006. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60: 205-209.
41. Genovese, F., G. Mancuso, M. Cuzzola, C. Biondo, C. Beninati, D. Delfino, and G. Teti. 1999. Role of IL-10 in a neonatal mouse listeriosis model. J. Immunol. 163: 2777-2782.
42. Sun, C. M., E. Deriaud, C. Leclerc, and R. Lo-Man. 2005. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22: 467-477.
43. Belderbos, M. E., G. M. van Bleek, O. Levy, M. O. Blanken, M. L. Houben, L. Schuijff, J. L. Kimpen, and L. Bont. 2009. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPSinduced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 133: 228-237.
44. Wynn, J. L., N. Z. Cvijanovich, G. L. Allen, N. J. Thomas, R. J. Freishtat, N. Anas, K. Meyer, P. A. Checchia, R. Lin, T. P. Shanley, et al 2011. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol. Med. 17: 1146-1156.
45. Harris, M. C., A. T. Costarino, Jr., J. S. Sullivan, S. Dulkerian, L. McCawley, L. Corcoran, S. Butler, and L. Kilpatrick. 1994. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J. Pediatr. 124: 105-111.
46. Gibson, R. L., G. J. Redding, W. R. Henderson, and W. E. Truog. 1991. Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am. Rev. Respir. Dis. 143: 598-604.
47. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61: 227-235.
48. Teti, G., G. Mancuso, F. Tomasello, and M. S. Chiofalo. 1992. Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci. Circ. Shock 38: 138-144.
49. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and B. J. Kullberg. 2004. Tolllike receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718.
50. Rios-Santos, F., J. C. Alves-Filho, F. O. Souto, F. Spiller, A. Freitas, C. M. Lotufo, M. B. Soares, R. R. Dos Santos, M. M. Teixeira, and F. Q. Cunha. 2007. Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase-derived nitric oxide. Am. J. Respir. Crit. Care Med. 175: 490-497.
51. Zou, L., Y. Feng, Y. J. Chen, R. Si, S. Shen, Q. Zhou, F. Ichinose, M. ScherrerCrosbie, and W. Chao. 2010. Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 38: 1335-1342.
52. Delano, M. J., K. M. Kelly-Scumpia, T. C. Thayer, R. D. Winfield, P. O. Scumpia, A. G. Cuenca, P. B. Harrington, K. A. O'Malley, E. Warner, S. Gabrilovich, et al. 2011. Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. J. Immunol. 187: 911-918.
53. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
54. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, J. Schweitzer, W. Vogt, and I. W. Browder. 2003. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31: 1808-1818.
55. Boonstra, A., R. Rajsbaum, M. Holman, R. Marques, C. Asselin-Paturel, J. P. Pereira, E. E. Bates, S. Akira, P. Vieira, Y. J. Liu, et al 2006. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177: 7551-7558.
56. Boomer, J. S., K. To, K. C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, T.L. Bricker, S. D. Jarman, II, D. Kreisel, A. S. Krupnick, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605.
57. Hotchkiss, R. S., and S. Opal. 2010. Immunotherapy for sepsis - a new approach against an ancient foe. N. Engl. J. Med. 363: 87-89.
58. Oberholzer, A., C. Oberholzer, and L. L. Moldawer. 2002. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an antiinflammatory drug. Crit. Care Med. 30: S58-S63.
59. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053.
60. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
61. Costa, A., R. Gupta, G. Signorino, A. Malara, F. Cardile, C. Biondo, A. Midiri, R. Galbo, P. Trieu-Cuot, S. Papasergi, et al. 2012. Activation of the NLRP3 inflammasome by group B streptococci. J. Immunol. 188: 1953-1960.
62. Mancuso, G., M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. Teti, and C. Beninati. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10: 587-594.
63. Charrel-Dennis, M., E. Latz, K. A. Halmen, P. Trieu-Cuot, K. A. Fitzgerald, D. L. Kasper, and D. T. Golenbock. 2008. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 4: 543-554.